Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christopher C. Paustian
Observed names:
C Paustian,
C. Paustian,
C.C. Paustian,
Christopher C Paustian,
Christopher Paustian
Institution:
Providence Portland Medical Center
Observed institutions:
Cleveland Clinic,
Kent State University,
Oregon Health & Science University,
Providence Portland Medical Center,
UbiVac (United States),
Viralytics Limited (Australia),
Cleveland Clinic Research
show all 7
OpenAlex ID:
A5009909972
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
2018
·
Franck Pagès
, Bernhard Mlecnik
, et al.
·
The Lancet
·
2,248
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer
2020
·
Bernhard Mlecnik
, Carlo Bifulco
, et al.
·
Journal of Clinical Oncology
·
234
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells
2008
·
Peter A. Cohen
, Gary K. Koski
, et al.
·
Blood
·
53
PDF
Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment
2015
·
Robert HI Andtbacka
, Brendan D Curti
, et al.
·
Journal for ImmunoTherapy of Cancer
·
39
PDF
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer
2023
·
Bernhard Mlecnik
, Alessandro Lugli
, et al.
·
Cancers
·
36
PDF
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells
2014
·
Wei Ye
, Yun Xing
, et al.
·
Journal of Translational Medicine
·
28
PDF
Extracellular ATP and Toll-Like Receptor 2 Agonists Trigger in Human Monocytes an Activation Program That Favors T Helper 17
2013
·
Christopher Paustian
, Patricia Taylor
, et al.
·
PLoS ONE
·
26
PDF
Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells
2010
·
Christopher Paustian
, Richard Caspell
, et al.
·
Human Immunology
·
23
J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells
2010
·
P.R. Taylor
, G.K. Koski
, et al.
·
Vaccine
·
23
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study
2022
·
Bernhard Mlecnik
, Toshihiko Torigoe
, et al.
·
Cancers
·
19
PDF
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
2017
·
Rachel E. Sanborn
, Helen J. Ross
, et al.
·
Journal for ImmunoTherapy of Cancer
·
19
PDF
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts
2016
·
Sonja Althammer
, Keith Steele
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
Maturation of dendritic cell precursors into IL12-producing DCs by J-LEAPS immunogens
2010
·
Patricia R. Taylor
, Christopher C. Paustian
, et al.
·
Cellular Immunology
·
18
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
2016
·
Casey Ager
, Matthew Reilley
, et al.
·
Journal for ImmunoTherapy of Cancer
·
17
PDF
3336 Phase II CALM extension study: Enhanced immune-cell infiltration within the tumour micro-environment of patients with advanced melanoma following intralesional delivery of Coxsackievirus A21
2015
·
R.H.I. Andtbacka
, B. Curti
, et al.
·
European Journal of Cancer
·
11
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
2014
·
Traci Hilton
, Rachel Sanborn
, et al.
·
Journal for ImmunoTherapy of Cancer
·
8
PDF
T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts).
2017
·
Bernard A. Fox
, Brian C. Boulmay
, et al.
·
Journal of Clinical Oncology
·
7
Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
2014
·
Zipei Feng
, Tarsem Moudgil
, et al.
·
Journal for ImmunoTherapy of Cancer
·
7
PDF
480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12
2020
·
Shawn Jensen
, Christopher Twitty
, et al.
·
Journal for ImmunoTherapy of Cancer
·
6
PDF
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
2018
·
Rieneke van de Ven
, Traci L. Hilton
, et al.
·
OncoImmunology
·
6
P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC
2017
·
Rachel Sanborn
, Brian Boulmay
, et al.
·
Journal of Thoracic Oncology
·
4
PDF
Dynamics of tumor response in advanced melanoma patients treated with Coxsackievirus A21.
2016
·
Robert Hans Ingemar Andtbacka
, Brendan D. Curti
, et al.
·
Journal of Clinical Oncology
·
4
Abstract CT112: An off-the-shelf multivalent vaccine containing cancer’s dark matter, DPV-001, combined with PD-1 +/- GITR in head & neck cancer: safety, efficacy, and immunodynamics from the phase 1 GITRVax trial
2024
·
Rom S. Leidner
, Christopher Paustian
, et al.
·
Cancer Research
·
3
Abstract 38: Development of a DC-targeted microvesicle vaccine to intercept the progression of oral preneoplasia to cancer
2017
·
R. Bryan Bell
, Rom Leidner
, et al.
·
Clinical Cancer Research
·
3
Adoptive TIL in HPV-negative oral scca
2015
·
Rom Leidner
, Brendan D Curti
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
PDF
Show more works
View as search
Works count:
59
Citation count:
3,095
H-index:
15
I10-index:
16
Year
Topic
Type